A new study has suggested that long Covid, which refers to 'SARS-CoV-2' symptoms that persist despite having healed from the initial infection, and ...

Microbix Biosystems Inc. ( MBX:CA) Q1 2026 Earnings Call February 12, 2026 10:00 AM EST All right. I think we can get started. Good morning, everyone. Thanks for joining us. We have an update from ...

It's not easy to tell these health conditions apart based on their symptoms alone. Find out about the differences between these illnesses.

In its main clinical trial, mRNA-1010 was shown to be 26.6% more effective than the comparator flu shot in adults aged 50 ...

Regeneron-invented therapies, including first-time Phase 3 presentations for two distinct investigational allergen-blocking antibodies for cat and birch allergies ...

The latest update on hVIVO nudges the modelled fair value estimate from £0.1744 per share to £0.1756, a small move that still signals a fresh look at the company’s risk and growth profile. Behind this ...

Coventry City matchday blog from CoventryLive as Sky Blues reporter Andy Turner brings you live updates from all of today's ...

The future of healthcare will be built by ecosystems that learn, fail, adapt and scale – together Read more at The Business ...

Multiple randomized clinical trials and electronic health record studies now show that metformin, a widely used and ...

The Traveler-Based Genomic Surveillance (TGS) program began in 2021 and is a voluntary way for international travelers to ...

LIBERTY is part of the Company’s broader REVOLUTION clinical program designed to elaborate the profile of monoclonal antibody-mediated prophylaxis from COVID-19 and the potential medical benefits to ...